On February 26, Liu Jingzhen, Secretary of the Party Committee and Chairman of Sinopharm, and his delegation visited the University of Macau, where the two sides signed a strategic cooperation framework agreement and held talks on further deepening cooperation. President of the University of Macau Mr. Song Yonghua, Vice President Mr. Xu Jian, Vice President of Sinopharm Mr. Hu Jianwei, Vice President of Sinopharm Mr. Dong Zenghe, Vice President of Sinopharm and Vice President of Sinopharm Mr. Jin Bin attended the event.

Before the meeting, the two sides held a signing ceremony for the strategic cooperation framework agreement, in which Sinopharm's Vice General Manager Dong Zenghe and University of Macau's Vice President Xu Jian signed the agreement on behalf of the two sides.

Mr. Liu Jingzhen, Chairman of the Board of Directors of Sinopharm, introduced Sinopharm's innovative development strategy and the key work it has done to help the development of Macao-Qingyuan. He said that the CPC Central Committee and State Council attach great importance to the development of Macao-Qingyuan, and the Macao SAR government is actively promoting the "1+4" moderate and diversified economic development. The cooperation between Sinopharm and the University of Macao will give full play to the strengths of both sides, and set up joint research institutes in the fields of biomedicine, traditional Chinese medicine, and big health to strengthen the integration of the relevant fields of industry, academia and research, and to assist the innovative development of life and health industries in Macao-Qingyuan. The cooperation between Sinopharm and the University of Macau will strengthen the integration of industry, academia and research in related fields and help Macao-Qingyuan to develop innovatively in life and health industry.

President Song Yonghua introduced the advantages and future development plan of the University of Macau, and said that the University of Macau has always attached great importance to the development of education and research and development in the field of health sciences, and has continuously strengthened the construction of academic disciplines, and actively cooperated with the national development strategy to enhance the support for the development of biomedicine and big health industry.

The two sides held talks on the implementation of strategic cooperation, realization of project landing, promotion of achievement transformation, deepening of collaborative innovation, accelerating the training of talents, and carried out in-depth exchanges on the intention and mode of cooperation in the fields of biopharmaceuticals, chemical pharmaceuticals, traditional Chinese medicines and big health.

The talks and signing of the contract signify that the two sides have reached a comprehensive and in-depth substantive cooperation in a number of areas, in order to take practical action to implement the spirit of the 20th CPC National Congress, and to fully serve the strategy of "Healthy China" and Macau's "1+4" moderate and diversified development strategy. The integration and mutual promotion of the innovation chain, industrial chain and talent chain in the field of medicine and health of the two sides will create a new paradigm of cooperation between the industry, academia and research institutes of the two places, and help enhance the scientific and technological strength of Macao-Qingdao's biomedical and big health strategy, which is of great significance for the two sides to take part in the implementation of the national strategy of innovation-driven development.

https://mp.weixin.qq.com/s/slPVtrU7qTen144Dy895pQ